232 related articles for article (PubMed ID: 25687855)
1. ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection.
Hwang HW; Ha SY; Bang H; Park CK
Cancer Res Treat; 2015 Oct; 47(4):853-61. PubMed ID: 25687855
[TBL] [Abstract][Full Text] [Related]
2. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK
Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806
[TBL] [Abstract][Full Text] [Related]
3. [Expression of ATAD2 in different liver lesions and its clinical significance].
Liu F; Zhou X; Ji HH; Li H; Xiang FG
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):339-343. PubMed ID: 28763839
[No Abstract] [Full Text] [Related]
4. Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma.
Bang H; Ha SY; Hwang SH; Park CK
Cancer Res Treat; 2015 Oct; 47(4):844-52. PubMed ID: 25687862
[TBL] [Abstract][Full Text] [Related]
5. Integrated Bioinformatics Analysis of the Clinical Value and Biological Function of ATAD2 in Hepatocellular Carcinoma.
Meng X; Wang L; Zhu B; Zhang J; Guo S; Li Q; Zhang T; Zheng Z; Wu G; Zhao Y
Biomed Res Int; 2020; 2020():8657468. PubMed ID: 32462022
[TBL] [Abstract][Full Text] [Related]
6. NADPH Oxidase 1 and NADPH Oxidase 4 Have Opposite Prognostic Effects for Patients with Hepatocellular Carcinoma after Hepatectomy.
Ha SY; Paik YH; Yang JW; Lee MJ; Bae H; Park CK
Gut Liver; 2016 Sep; 10(5):826-35. PubMed ID: 27282266
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
8. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
[TBL] [Abstract][Full Text] [Related]
9. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
Lu WJ; Chua MS; So SK
Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
[TBL] [Abstract][Full Text] [Related]
10. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
[TBL] [Abstract][Full Text] [Related]
11. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
Ha SY; Song DH; Hwang SH; Cho SY; Park CK
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):171-7. PubMed ID: 25865690
[TBL] [Abstract][Full Text] [Related]
12. Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
Wang ZS; Guo WD; Wu LQ; Yi X; Geng C; Li YJ; Yao RY
PLoS One; 2015; 10(11):e0142727. PubMed ID: 26588210
[TBL] [Abstract][Full Text] [Related]
13. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
[TBL] [Abstract][Full Text] [Related]
15. Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.
Ha SY; Kim JH; Yang JW; Bae H; Cho HY; Park CK
Pathol Res Pract; 2016 Jul; 212(7):616-21. PubMed ID: 27083241
[TBL] [Abstract][Full Text] [Related]
16. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
18. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma.
Ekin U; Yuzugullu H; Ozen C; Korhan P; Bagirsakci E; Yilmaz F; Yuzugullu OG; Uzuner H; Alotaibi H; Kirmizibayrak PB; Atabey N; Karakülah G; Ozturk M
J Gastrointest Cancer; 2021 Dec; 52(4):1356-1369. PubMed ID: 34738187
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of des-γ-carboxyl prothrombin in living-donor liver transplantation for recurrent hepatocellular carcinoma.
Harimoto N; Yoshida Y; Kurihara T; Takeishi K; Itoh S; Harada N; Tsujita E; Yamashita YI; Uchiyama H; Soejima Y; Ikegami T; Yoshizumi T; Kawanaka H; Ikeda T; Shirabe K; Saeki H; Oki E; Kimura Y; Maehara Y
Transplant Proc; 2015 Apr; 47(3):703-4. PubMed ID: 25819732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
